1
|
Soleimani R, Ansari F, Hamzehgardeshi Z, Elyasi F, Moosazadeh M, Yazdani F, Shahidi M, Shiraghaei N, Karimi M, Hemati T, Pejmanmanesh M. Perceived stress reduction through an infertility coaching program: a randomized controlled clinical trial. Sci Rep 2023; 13:14511. [PMID: 37666933 PMCID: PMC10477300 DOI: 10.1038/s41598-023-41845-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2022] [Accepted: 08/31/2023] [Indexed: 09/06/2023] Open
Abstract
Infertility has been recognized as a distressing experience among couples worldwide, cutting across various cultures. This present study was conducted to assess the impact of a supportive stress management program led by an infertility coach for women undergoing fertility treatment. This randomized controlled clinical trial study was performed on 60 infertile women undergoing assisted reproductive techniques at Maryam Infertility Center located in Sari in 2018. After random allocation in two groups, 30 individuals were in the intervention group and 30 in the control group. The intervention program was implemented according to the infertility coach's counseling protocol in six stages. The control group received only routine ward counseling. In order to measure stress, the Newton Infertility Stress Questionnaire was used firstly before intervention and then after oocyte puncture, embryo transfer, and pregnancy testing. Data analysis was performed using SPSS statistical software version 18 and Shapiro-Wilk, Chi-square, Mann-Whitney, independent t-test, Friedman test, Wilcoxon test, GEE test, and Cohen's effect size. Our analysis approach has also been based on the analysis of (ITT). The significance level was 0.05. The mean ± SD scores of infertility perceived stress before the intervention in the control was 146.16 ± 16.90 and the intervention group was 156.53 ± 9.31, after intervention at the time of oocyte puncture in the controls was 165.36 ± 8.98 and the intervention group was 155.83 ± 10.70, at the day of embryo transfer in the control group was 156.35 ± 14.45 and in the intervention group was 123.58 ± 22.9 and in the pregnancy test day in the control group was 185.76 ± 26.56 and in the intervention group was 127.61 ± 21.57 (P < 0.001). According to Friedman test, the mean of stress in three situations after the intervention showed a significant difference in reduction of the mean of stress (P < 0.001). In the control group, the stress score of the samples had an increasing trend, which was significant during the measurement steps based on Friedman test results (P < 0.001). In the intervention group, paired t-test results showed no significant comparing mean score of Newton's infertility stress before and after oocyte puncture day (P = 0.711), comparing the mean of stress before and after pregnancy test day (P = 0.003) and also comparing of mean stress before and after pregnancy on the day of embryo transfer according to Wilcoxon test (P < 0.001). And comparing mean stress before and after pregnancy test day, paired t-test (P = 0.001) showed significant statistical differences. According to the results of the GEE test, changes in stress scores over time were significant between the two groups (P < 0.001), as well as the effect of stress on oocyte puncture day (0.41), embryo transfer day (1.69), pregnancy test day (P < 0.001) (2.46) had a significant effect on the day of embryo transfer and pregnancy test day. Based on the results of this study, the infertility coach program demonstrated the ability to decrease the perceived stress related to infertility. Additionally, it showed potential in enhancing treatment outcomes, such as oocyte count and positive pregnancy results, among infertile women undergoing assisted reproductive techniques.Trial registration: Iranian Registry for Clinical Trial (the link to trial: https://www.irct.ir/trial/33357 ). Registered 11-11-2018.
Collapse
Affiliation(s)
- Roghoyeh Soleimani
- Student Research Committee, Nasibeh Faculty of Nursing and Midwifery, Mazandaran University of Medical Sciences, Sari, Iran
| | - Fatemeh Ansari
- Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
| | - Zeinab Hamzehgardeshi
- Sexual and Reproductive Health Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
| | - Forouzan Elyasi
- Psychiatry and Behavioral Sciences Research Center, Sexual and Reproductive Health Research Center, Addiction Institute, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
| | - Mahmood Moosazadeh
- Epidemiology, Gastrointestinal Cancer Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
| | | | - Maryam Shahidi
- IVF Ward, Hazrat-e Maryam Fertility Center (HMFC), Sari, Iran
| | | | - Mahtab Karimi
- IVF Ward, Hazrat-e Maryam Fertility Center (HMFC), Sari, Iran
| | - Tayebeh Hemati
- IVF Ward, The MOM Specialized Centre for Reproductive Health and Infertility, Tehran, Iran
| | | |
Collapse
|
2
|
Hamzehgardeshi Z, Kalantari F, Bakouei F, Moradi S, Peyvandi S, Shahidi M, Feizi A. Investigation of social capital and its relationship with emotional adjustment in infertile couples: A cross-sectional study. Int J Reprod Biomed 2022; 20:91-100. [PMID: 35434478 PMCID: PMC9002165 DOI: 10.18502/ijrm.v20i2.10501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2020] [Revised: 04/05/2021] [Accepted: 06/30/2021] [Indexed: 11/24/2022] Open
Abstract
Background: Infertility is an abnormal event in the life of families and can have various consequences on a personal and social level. Therefore, infertile couples need to manage their emotional responses. Social capital, as one of the social determinants of health, can affect mental health.
Objective: This study was conducted to determine the relationship between social capital and emotional adjustment in infertile couples.
Materials and Methods: This cross-sectional study was conducted from October 2018 to February 2019 with 170 infertile couples visiting infertility centers in Sari, Iran. The data collection instruments included the social capital integrated questionnaire, an emotional adjustment scale and a demographic-reproductive checklist.
Results: All the social capital dimensions, except for the groups and networks dimension, had a score of higher than 50 (more than the mean score). Based on ANCOVA and the multiple linear regression results, the dimension of trust and solidarity had a significant negative relationship with emotional adjustment (p = 0.01), but no significant relationship was observed between the other social capital dimensions and emotional adjustment.
Conclusion: The trust and solidarity dimension had a significant relationship with emotional adjustment in infertile couples. Accordingly, increasing mutual trust between neighborhood residents can strengthen social capital, and in turn, improve emotional adjustment in infertile couples.
Key words: Social capital, Emotional adjustment, Infertility.
Collapse
Affiliation(s)
- Zeinab Hamzehgardeshi
- Sexual and Reproductive Health Research Center, Mazandaran University of Medical Sciences, Sari, Iran
- Department of Reproductive Health and Midwifery, Nasibeh Faculty of Nursing and Midwifery, Mazandaran University of Medical Sciences, Sari, Iran
| | - Fereshteh Kalantari
- Student Research Committee, Nasibeh Faculty of Nursing and Midwifery, Mazandaran University of Medical Sciences, Sari, Iran
| | - Fatemeh Bakouei
- Infertility and Health Reproductive Research Center, Health Research Institute, Department of Midwifery, Faculty of Nursing and Midwifery, Babol University of Medical Sciences, Babol, Iran
| | - Siavash Moradi
- Medical Education Development Center, Mazandaran University of Medical Sciences, Sari, Iran
| | - Sepideh Peyvandi
- Infertility Center, Mazandaran University of Medical Sciences, Sari, Iran
| | - Maryam Shahidi
- Department of Biochemistry, Biophysics and Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
- Hazrat-e Maryam Fertility Center, Sari, Iran
| | - Atefe Feizi
- Imam Khomeini Infertility Treatment Center, Sari, Iran
| |
Collapse
|
3
|
Kiani Z, Simbar M, Hajian S, Zayeri F, Shahidi M, Saei Ghare Naz M, Ghasemi V. The prevalence of anxiety symptoms in infertile women: a systematic review and meta-analysis. Fertil Res Pract 2020; 6:7. [PMID: 32313665 PMCID: PMC7157980 DOI: 10.1186/s40738-020-00076-1] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/05/2019] [Accepted: 03/31/2020] [Indexed: 12/15/2022]
Abstract
BACKGROUND Infertile women are exposed more frequently to anxiety risk than are infertile men, thereby adversely affecting the procedures with which they are treated and the quality of their lives. Yet, this problem is often disregarded. This study accordingly determined the prevalence of anxiety symptoms among infertile women. METHODS All Persian and English studies published from the early 2000s to May 2019 were searched in international (i.e., PubMed, the Cochrane Library, Web of Science, Scopus, Embase, and PsycINFO) and national (i.e., SID, Magiran) databases as well as through Google Scholar. After the titles and abstracts of the articles were reviewed, their quality was evaluated, and relevant works for examination were selected in consideration of established inclusion and exclusion criteria. The risk of biases of individual studies according to Newcastle - Ottawa Scale was assessed. The heterogeneity of the studies was assessed using the I2 statistic, and indicators of publication bias were ascertained using Egger's test. Stata (version 14) was employed in analyzing the findings. RESULTS Thirteen studies having a collective sample size of 5055 infertile women were subjected to meta-analysis, with study heterogeneity incorporated into a random effects model. The findings indicated that 36% of the infertile women involved in the evaluated studies self-reported their experience with anxiety. The pooled prevalence of the condition among the subjects was 36.17% [95% confidence interval (CI): 22.47-49.87]. The pooled prevalence levels in low- and middle-income countries and high-income countries were 54.24% (95% CI: 31.86-78.62) and 25.05% (95% CI: 15.76-34.34), respectively. The results revealed no evidence of publication bias (P Egger's test = 0.406). CONCLUSION Considering the prevalence of anxiety in infertile women and its effects on health processes and quality of life, this problem requires serious consideration and planning for effective intervention, especially in low- and middle-income nations.
Collapse
Affiliation(s)
- Zahra Kiani
- Student Research Committee, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Masoumeh Simbar
- Midwifery and Reproductive Health Research Center, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Sepideh Hajian
- Midwifery and Reproductive Health Research Center, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Farid Zayeri
- Proteomics Research Center and Department of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Maryam Shahidi
- Department of Biochemistry and Biophysics, Mazandaran University of Medical Sciences, Sari, Iran
- Hazrat-e Maryam Fertility Center, Sari, Iran
| | - Marzieh Saei Ghare Naz
- Student Research Committee, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Vida Ghasemi
- Student Research Committee, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| |
Collapse
|
4
|
Khalili-Savadkouhi S, Karimpour Malekshah A, Mirhoseini M, Moosazadeh M, Shahidi M. The Influence of Light on Apoptosis in Preimplantation Mouse Embryos In Vitro. RMM 2019. [DOI: 10.18502/rmm.v6i3.4607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Background: In vitro culture of mammalian embryos can slow or stop growth completely. This may be due to the medium used, pH, temperature, or light. There is considerable concern about the harmful effect of light in the laboratory environment. Cell number and apoptosis are useful parameters that indicate embryonic development and health. In this study, we assessed these two factors in the blastocyst. Materials and methods: A total of 128 embryos were extracted from NMRI mice at the 2-cell stage and were divided into 4 groups. The embryos were exposed to light for 0, 5, 15, and 30 min, and then cultured for 96 h. The degree of embryonic development were recorded every 24 h. Furthermore, several morphologically normal blastocysts were evaluated using the TUNEL assay. Results: There was no significant difference in developmental stages between the experimental and control groups. An evaluation of the percentage of blastomeres and apoptotic cells revealed significant differences among the four groups. The maximum number of apoptotic blastomeres was observed in the group exposed to light for 30 minutes. Conclusion: Up to thirty minutes of white fluorescent light can induce apoptosis in blastomeres, but it does not prevent embryo development.
Collapse
|
5
|
Hamzehgardeshi Z, Yazdani F, Elyasi F, Moosazadeh M, Peyvandi S, Samadaee Gelehkolaee K, Shahidi M. The efficacy of group counselling on perceived stress among infertile women undergoing in vitro fertilization treatment: An RCT. Int J Reprod Biomed 2019; 17. [PMID: 31435585 PMCID: PMC6652162 DOI: 10.18502/ijrm.v17i1.3821] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2017] [Revised: 06/28/2018] [Accepted: 07/08/2018] [Indexed: 11/24/2022] Open
Abstract
Background One of the stressful and critical experiences that threat the individual, family, marital, and social stability is infertility. Objective To identify the effects of midwifery-led counselling programs on the perceived stress of the women undergoing assisted reproductive treatment. Materials and Methods In this randomized clinical trial, 50 infertile women who underwent in vitro fertilization treatment for the first time were enrolled in two groups. The intervention group received six sessions of group counselling by M.Sc. midwifery of counseling student and the control group received only the routine care. All participants filled Newton's standard questionnaire before and at the time of puncture, embryo transfer and the pregnancy test. Results The mean ± SD scores for the perceived infertility stress before the intervention in the control and the intervention groups were 167.92 ± 12.14 and 166.75 ± 13.27, respectively. The mean of perceived stress after intervention at the time of oocyte puncture in the control and case group were 177.12 ± 19.37 and 115.75 ± 13.88, at the time of embryo transfer were 179.40 ± 18.34 and 118.08 ± 15.37, and at the time of pregnancy test was 183.76 ± 14.97 and 120.50 ± 16.24, respectively. The perceived
stress of infertility after intervention were statistically significant in the two group (p ≤ 0.001). Conclusion Group counselling is one of the effective methods for reducing the perceived stress in the women undergoing assisted reproductive treatment.
Collapse
Affiliation(s)
- Zeinab Hamzehgardeshi
- Sexual and Reproductive Health Research Center, Mazandaran University of Medical Sciences, Sari, Iran.,Department of Reproductive Health and Midwifery, School of Nursing and Midwifery, Mazandaran University of Medical Sciences, Sari, Iran.,Traditional and Complementary Medicine Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran
| | - Fereshteh Yazdani
- Midwifery Counseling, Mazandaran University of Medical Sciences, Sari, Iran.,Student Research Committee, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Forouzan Elyasi
- Department of Psychiatry, Psychiatry and Behavioral Sciences Research Center, Addiction Institute, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
| | - Mahmood Moosazadeh
- Health Science Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran
| | | | - Keshvar Samadaee Gelehkolaee
- Department of Reproductive Health and Midwifery, Tehran Nursing and Midwifery Faculty, Tehran University of Medical Sciences, Tehran, Iran
| | - Maryam Shahidi
- Department of Medical Physics, Mazandaran Medical University, Mazandaran, Iran.,Hazrat-e Maryam Fertility Center (HMFC), Sari, Iran
| |
Collapse
|
6
|
Shiran MB, Barzegar Marvasti M, Shakeri-Zadeh A, Shahidi M, Tabkhi N, Farkhondeh F, Kalantar E, Asadinejad A. Enhancement of Toxic Substances Clearance from Blood Equvalent Solution and Human Whole Blood through High Flux Dialyzer by 1 MHz Ultrasound. J Biomed Phys Eng 2017; 7:107-116. [PMID: 28580332 PMCID: PMC5447247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2016] [Accepted: 10/08/2016] [Indexed: 11/24/2022]
Abstract
BACKGROUND Hemodialysis is a process of removing waste and excess fluid from blood when kidneys cannot function efficiently. It often involves diverting blood to the filter of the dialysis machin to be cleared of toxic substances. Fouling of pores in dialysis membrane caused by adhesion of plasma protein and other toxins will reduce the efficacy of the filtre. OBJECTIVE In This study, the influence of pulsed ultrasound waves on diffusion and the prevention of fouling in the filter membrane were investigated. MATERIAL AND METHODS Pulsed ultrasound waves with frequency of 1 MHz at an intensity of 1 W/cm2 was applied to the high flux (PES 130) filter. Blood and blood equivalent solutions were passed through the filter in separate experimental setups. The amount of Creatinine, Urea and Inulin cleared from both blood equvalent solution and human whole blood passed through High Flux (PES 130) filter were measured in the presence and absence of ultrasound irradiation. Samples were taken from the outlet of the dialyzer every five minutes and the clearance of each constituent was calculated. RESULTS Statistical analysis of the blood equvalent solution and whole blood indicated the clearance of Urea and Inulin in the presence of ultrasound increased (p<0.05), while no significant effects were observed for Creatinine. CONCLUSION It may be concluded that ultrasound, as a mechanical force, can increase the rate of clearance of some toxins (such as middle and large molecules) in the hemodialysis process.
Collapse
Affiliation(s)
- M B Shiran
- Department of Medical Physics, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - M Barzegar Marvasti
- Department of Medical Physics, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - A Shakeri-Zadeh
- Department of Medical Physics, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - M Shahidi
- Department of Hematology, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran
| | - N Tabkhi
- Company of Samin Teb Soroush (Smart), Tehran, Iran
| | - F Farkhondeh
- Department of Medical Physics, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - E Kalantar
- Department of Immunology, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran
| | | |
Collapse
|
7
|
Abstract
BACKGROUND Phototherapy is believed to be a safe method for the management of hyperbilirubinemia. However, there are some controversial issues regarding the genotoxic effects of phototherapy on DNA. The aim of this study was to investigate morphologically both phototherapy-induced DNA double-strand breaks (DSBs) and apoptosis in lymphocytes derived from jaundiced and non-jaundiced neonates. METHODS Newborns were divided into three groups, including phototherapy-treated (PT, n=30) jaundiced newborns with total serum bilirubin (TSB) levels >15 mg/dl, non-treated jaundiced newborns (C+, n=27), as positive, as well as healthy negative (C-, n=30) controls with TSB levels ranging from 10 and 15 mg/dl and less than 5 mg/dl, respectively. Lymphocytes were isolated from whole blood samples by Ficoll-isopaque density gradient centrifugation and then assessed for DNA damage and apoptosis before and 24 hours after incubation at 37°C in 5% CO2 using the neutral comet assay. RESULTS DSB levels were significantly much higher in the PT group compared to the controls before incubation but decreased remarkably after the incubation period. As expected, no statistical differences were found between the two control groups before and after incubations. The frequency of apoptotic cells showed no significant differences among all the three groups before incubation; however, it was significantly increased in the PT group after incubation. CONCLUSION It seems that phototherapy in jaundiced infants is able not only to induce apoptosis in newborn lymphocytes but also to affect indirectly DNA integrity.
Collapse
Affiliation(s)
- Seyed Alireza Mesbah-Namin
- Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran,Iran
| | - Maryam Shahidi
- Department of Biochemistry and Biophysics, Faculty of Medicine, Mazandaran University of Medical Sciences, Mazandaran, Sari, Iran
| | - Maryam Nakhshab
- Department of Pediatrics, Faculty of Medicine, Mazandaran University of Medical Sciences, Mazandaran, Sari, Iran
| |
Collapse
|
8
|
Shirazi MM, Shabestani-Monfared A, Shahidi M, Amiri M, Abedi SM, Borzoueisileh S, Gorji KEN. Radio-adaptive Response in Myocardial Perfusion Imaging Induced by Technetium-99m. Indian J Nucl Med 2017; 32:7-10. [PMID: 28242975 PMCID: PMC5317080 DOI: 10.4103/0972-3919.198446] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
Purpose of the Study: Low dose radiation will induce adaptation and following exposure to an adaptive dose, the cells are more resistance to following challenging doses. This phenomenon is known as radio-adaptive response. The aim of this study was to investigate the percentage of apoptotic cells in the peripheral blood samples of the patients which undergo myocardial perfusion imaging (MPI) with technetium-99m (Tc-99m) before thallium scan to assess the induction of radio-adaptive response. Materials and Methods: In this study, 97 samples from 74 patients, referred to nuclear medicine center of Mazandaran Heart Hospital for MPI, which had no history of diagnostic, therapeutic, occupational, and radioactive exposures during past 2 years, were provided. The participants were classified into four groups including control, patients which were scanned solely with technetium, the patients which examined by thallium and the last group were the patients that examined by technetium followed by thallium. Then 2 ml Peripheral blood samples were obtained, and after 24 h incubating, the samples were studied by neutral comet assay. Statistical analysis was carried out using Student's t-test along with one-way analysis of variance. Results: The mean percentage of apoptotic cells in the exposed groups were higher than the control. Furthermore, among exposed groups, the apoptotic cells in thallium group were more than others and this index was significantly lower in the group which was undergone technetium administration before thallium scan. Conclusions: These findings suggest that exposure to Tc-99m could induce a radio-adaptive response against the exposure of thallium-201.
Collapse
Affiliation(s)
- Mohammad Mehdi Shirazi
- Cellular and Molecular Biology Research Center, Babol University of Medical Sciences, Babol, Iran
| | - Ali Shabestani-Monfared
- Cellular and Molecular Biology Research Center, Babol University of Medical Sciences, Babol, Iran; Department of Medical Physics, Babol University of Medical Sciences, Babol, Iran
| | - Maryam Shahidi
- Department of Medical Physics, Mazandaran University of Medical Sciences, Sari, Iran
| | - Mehrangiz Amiri
- Department of Nuclear Medicine, Babol University of Medical Sciences, Babol, Iran
| | - Seyed Mohammad Abedi
- Department of Nuclear Medicine, Mazandaran University of Medical Sciences, Sari, Iran
| | - Sajad Borzoueisileh
- Cellular and Molecular Biology Research Center, Babol University of Medical Sciences, Babol, Iran
| | | |
Collapse
|
9
|
Rafat N, Monfared AS, Shahidi M, Pourfallah TA. The modulating effect of royal jelly consumption against radiation-induced apoptosis in human peripheral blood leukocytes. J Med Phys 2016; 41:52-7. [PMID: 27051171 PMCID: PMC4795418 DOI: 10.4103/0971-6203.177281] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
The present work was designed to assess the radioprotective effect of royal jelly (RJ) against radiation-induced apoptosis in human peripheral blood leukocytes. In this study, peripheral blood samples were obtained on days 0, 4, 7, and 14 of the study from six healthy male volunteers taking a 1000 mg RJ capsule orally per day for 14 consecutive days. On each sampling day, all collected whole blood samples were divided into control and irradiated groups which were then exposed to the selected dose of 4 Gy X-ray. Percentage of apoptotic cells (Ap %) was evaluated for all samples immediately after irradiation (Ap0) and also after a 24 h postirradiation incubation at 37°C in 5% CO2 (Ap24) by the use of neutral comet assay. Concerning Ap0, collected data demonstrated that the percentage of apoptotic cells in both control and irradiated groups did not significantly change during the study period. However, with respect to Ap24, the percentage of apoptotic cells in irradiated groups gradually reduced during the experiment, according to which a significant decrease was found after 14 days RJ consumption (P = 0.002). In conclusion, the present study revealed the protective role of 14 days RJ consumption against radiation-induced apoptosis in human peripheral blood leukocytes.
Collapse
Affiliation(s)
- Navid Rafat
- Cellular and Molecular Biology Research Center, Department of Medical Physics, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
| | - Ali Shabestani Monfared
- Cellular and Molecular Biology Research Center, Department of Medical Physics, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
| | - Maryam Shahidi
- Department of Biophysics and Biochemistry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
| | - Tayyeb Allahverdi Pourfallah
- Department of Biophysics and Biochemistry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
| |
Collapse
|
10
|
Samadaee-Gelehkolaee K, McCarthy BW, Khalilian A, Hamzehgardeshi Z, Peyvandi S, Elyasi F, Shahidi M. Factors Associated With Marital Satisfaction in Infertile Couple: A Comprehensive Literature Review. Glob J Health Sci 2015; 8:96-109. [PMID: 26652079 PMCID: PMC4877237 DOI: 10.5539/gjhs.v8n5p96] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2015] [Revised: 08/31/2015] [Accepted: 07/23/2015] [Indexed: 11/25/2022] Open
Abstract
Background: Many factors impact on marital satisfaction. Related factors include demographic factors, assisted reproductive techniques, psychological health, quality of life, psychological, socioeconomic and family support, and sexual function. Methods: This study is a literature review of research studies conducted on factors associated with marital satisfaction in infertile couples. The current literature review search was undertaken using multiple databases selected from articles pertinent to the study. The selection of subjects was undertaken from1990 through 2015. The methodological quality was analyzed based on a checklist adopted from a systematic review. Quality assessment of full text studies was finally carried out by two reviewers. Results: The initial search yielded a list of 445 papers, and then reviewers studied titles and abstracts. Thereafter, 69 papers were incorporated, and researchers reviewed summaries of all of the searched articles. Finally, the researchers utilized the data gained from 64 full articles so as to compile this review paper. Reviewing the studies conducted on marital satisfaction, they classified related findings into 6 categories: demographic factors, using fertility assisting methods, psychological health, life quality, economic, social, and family support, and sexual function. Conclusion: The results of this review article depicted that various factors play role in creating marriage life satisfaction in an infertile couple, so that paying attention to them can play an important role in continuing their treatment. Thus, to identify such factors is considered essential in their treatment protocol highly based on culture. Of the drawbacks of this research is that it has tried at best to employ the studies belonging to diverse countries with different cultures. Also, the number of the papers was considerably limited.
Collapse
Affiliation(s)
- Keshvar Samadaee-Gelehkolaee
- 1 Department of Reproductive Health and Midwifery, Nasibeh Nursing and Midwifery Faculty, Mazandaran University of Medical Sciences, Sari, Iran 2 Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
| | | | | | | | | | | | | |
Collapse
|
11
|
Ghasemi A, Pourfallah TA, Akbari MR, Babapour H, Shahidi M. Photo neutron dose equivalent rate in 15 MV X-ray beam from a Siemens Primus Linac. J Med Phys 2015; 40:90-4. [PMID: 26170555 PMCID: PMC4478650 DOI: 10.4103/0971-6203.158681] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2014] [Revised: 03/16/2015] [Accepted: 03/16/2015] [Indexed: 12/01/2022] Open
Abstract
Fast and thermal neutron fluence rates from a 15 MV X-ray beams of a Siemens Primus Linac were measured using bare and moderated BF3 proportional counter inside the treatment room at different locations. Fluence rate values were converted to dose equivalent rate (DER) utilizing conversion factors of American Association of Physicist in Medicine's (AAPM) report number 19. For thermal neutrons, maximum and minimum DERs were 3.46 × 10-6 (3 m from isocenter in +Y direction, 0 × 0 field size) and 8.36 × 10-8 Sv/min (in maze, 40 × 40 field size), respectively. For fast neutrons, maximum DERs using 9” and 3” moderators were 1.6 × 10-5 and 1.74 × 10-5 Sv/min (2 m from isocenter in +Y direction, 0 × 0 field size), respectively. By changing the field size, the variation in thermal neutron DER was more than the fast neutron DER and the changes in fast neutron DER were not significant in the bunker except inside the radiation field. This study showed that at all points and distances, by decreasing field size of the beam, thermal and fast neutron DER increases and the number of thermal neutrons is more than fast neutrons.
Collapse
Affiliation(s)
- A Ghasemi
- Department of Radiotherapy, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
| | - T Allahverdi Pourfallah
- Department of Biochemistry and Biophysics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
| | - M R Akbari
- Nuclear Science and Technology Research Institute, Tehran 14395-836, Iran
| | - H Babapour
- Department of Nuclear Engineering, Islamic Azad University, Sciences and Researches Branch, Tehran, Iran
| | - M Shahidi
- Department of Biochemistry and Biophysics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
| |
Collapse
|
12
|
Bahrami M, Hosseini S, Shahidi M. Comparison of electrochemical current noise signals arising from symmetrical and asymmetrical electrodes made of Al alloys at different pH values using statistical and wavelet analysis. Part II: Alkaline solutions. Electrochim Acta 2014. [DOI: 10.1016/j.electacta.2014.10.029] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
13
|
Wong PS, Ng ST, Shahidi M. Towards understanding the contractor's response to carbon reduction policies in the construction projects. International Journal of Project Management 2013. [DOI: 10.1016/j.ijproman.2012.11.004] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
14
|
Hirata M, Tashiro Y, Aizawa K, Endo K, Hirata M, Tashiro Y, Endo K, Aizawa K, Serizawa K, Hirata M, Yogo K, Tashiro Y, Endo K, Cases A, Portoles J, Calls J, Martinez-Castelao A, Munar MA, Segarra A, Samouilidou E, Pantelias K, Petras D, Mpakirtzi T, Pipili C, Chatzivasileiou G, Vasiliou K, Denda E, Grapsa E, Tzanatos H, Shoji S, Inaba M, Tomosugi N, Okuno S, Ichii M, Yamakawa T, Kurihara S, Barsan L, Stanciu A, Stancu S, Capusa C, Bratescu L, Mircescu G, Barsan L, Stanciu A, Stancu S, Capusa C, Mircescu G, Kuo KL, Hung SC, Lee TS, Tarng DC, Nistor I, Covic A, Goldsmith D, Garrido P, Fernandes J, Ribeiro S, Vala H, Parada B, Alves R, Belo L, Costa E, Santos-Silva A, Reis F, Abdulnabi K, Ullah A, Abdulateef A, Howse M, Khalil A, Fouqueray B, Hoffmann M, Addison J, Manamley N, Stamopoulos D, Mpakirtzi N, Afentakis N, Grapsa E, Yu KH, Chou J, Klaus S, Schaddelee M, Kashiwa M, Takada A, Neff T, Galle J, Claes K, Di Giulio S, Guerin A, Herlitz H, Kiss I, Wirnsberger G, Manamley N, Addison J, Fouqueray B, Froissart M, Winearls C, Martinez Castelao A, Cases Amenos A, Torre Carballada A, Torralba Iranzo FJ, Bronsoms Artero JM, Toran Monserrat D, Valles Prats M, Merino JL, Espejo B, Bueno B, Amezquita Y, Paraiso V, Kiss Z, Kerkovits L, Ambrus C, Kulcsar I, Szegedi J, Benke A, Borbas B, Ferenczi S, Hengsperger M, Kazup S, Nagy L, Nemeth J, Rozinka A, Szabo T, Szelestei T, Toth E, Varga G, Wagner G, Zakar G, Gergely L, Kiss I, Exarchou K, Tanahill N, Anthoney A, Khalil A, Ahmed S, Capusa C, Oprican R, Stanciu A, Lipan M, Stancu S, Chirculescu B, Mircescu G, Ferenczi S, Roger S, Malecki R, Farouk M, Dellanna F, Thomas M, Manamley N, Touam M, Chantrel F, Bouiller M, Hurot JM, Raphael T, Testa A, Veillon S, Vendrely B, Masoumi Z, Ahmadpoor P, Ghaderian SMH, Nafar M, Samavat S, Samadian F, Poorrezagholi F, Shahidi M, Riccio E, Visciano B, Capuano I, Memoli A, Mozzillo G, Memoli B, Pisani A. Anaemia in CKD 1-5. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
15
|
Shahidi M, Farrehi Moghaddam R, Gholamhosseinzadeh M, Hosseini S. Investigation of the cathodic process influence on the electrochemical noise signals arising from pitting corrosion of Al alloys using wavelet analysis. J Electroanal Chem (Lausanne) 2013. [DOI: 10.1016/j.jelechem.2013.01.020] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
16
|
O'Byrne K, Sequist L, Schuler M, Yamamoto N, Hirsh V, Mok T, Lungershausen J, Shahidi M, Palmer M, Yang JH. 32 LUX-Lung 3: Symptom and health-related quality of life results from a randomized phase III study in 1st-line advanced NSCLC patients harbouring EGFR mutations. Lung Cancer 2013. [DOI: 10.1016/s0169-5002(13)70032-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
17
|
Yamamoto N, Schuler M, O'Byrne K, Hirsh V, Mok T, Kato T, Yoshioka H, Okamoto I, Yokoyama A, Massey D, Jones H, Zazulina V, Shahidi M, Sequist L, Yang JH. Lux-Lung 3: Afatinib Versus Cisplatin and Pemetrexed in Japanese Patients with Adenocarcinoma of the Lung Harboring an EGFR Mutation. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)31932-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
18
|
Rashtchizadeh N, Ghorbanihaghjo A, Argani H, Mahmoudi Meimand S, Safa J, Vatankhahan H, Shahidi M. Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients. Ther Apher Dial 2012. [PMID: 23190522 DOI: 10.1111/j.1744-9987.2012.01097.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Serum receptor activator of nuclear factor-κ B ligand and osteoprotegrin are mediated to vascular calcification in the general population. Our knowledge is very sparse in hemodialysis and renal transplant patients. Receptor activator of nuclear factor-κ B ligand, osteoprotegrin, intact parathyroid hormone, calcium, and phosphorus were measured in blood samples of 45 hemodialysis and 45 age-matched renal transplant patients. Osteoprotegrin (P = 0.001) and intact parathyroid hormone (P = 0.001) levels in the hemodialysis patients were higher than the renal transplant recipients. Osteoprotegrin had positive correlation with duration of dialysis and age in the hemodialysis (r = 0.88, P = 0.001 and r = 0.34, P = 0.02, respectively) and renal transplant patients (r = 0.92, P = 0.001 and r = 0.46, P = 0.001, respectively). Hemodialysis patients have higher osteoprotegrin levels than the renal transplant recipients. It may act as a protective factor for renal osteodystrophy or only as a secondary phenomenon of advanced renal failure.
Collapse
Affiliation(s)
- Nadereh Rashtchizadeh
- Drug Applied Research Center Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
| | | | | | | | | | | | | |
Collapse
|
19
|
Yang J, Schuler M, Yamamoto N, O'Byrne K, Hirsh V, Mok T, Massey D, Zazulina V, Shahidi M, Sequist L. Activity of Afatinib in Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations in Lux-Lung 3, A Phase III Trial of Afatinib or Cisplatin/Pemetrexed in EGFR Mutation-Positive Lung Cancer. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)33845-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
20
|
Murakami H, Tamura T, Takahashi T, Nokihara H, Naito T, Nakamura Y, Nishio K, Seki Y, Sarashina A, Shahidi M, Yamamoto N. Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4). Cancer Chemother Pharmacol 2011; 69:891-9. [PMID: 22071596 DOI: 10.1007/s00280-011-1738-1] [Citation(s) in RCA: 70] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2011] [Accepted: 08/31/2011] [Indexed: 11/30/2022]
Abstract
PURPOSE This Phase I study determined the maximum-tolerated dose (MTD) of afatinib (Afatinib is an investigational compound and its safety and efficacy have not yet been established) (BIBW 2992; trade name not yet approved by FDA), an irreversible inhibitor of epidermal growth factor receptor (EGFR)/human epidermal growth factor receptor (HER)1 and 2, up to a dose of 50 mg/day in advanced non-small cell lung cancer (NSCLC), to establish the recommended dose for Phase II. METHODS Patients with advanced NSCLC who had received prior platinum-doublet chemotherapy and/or erlotinib/gefitinib therapy, or who were ineligible for, or not amenable to, treatment with established therapies, received oral afatinib once daily. The MTD was determined based on dose-limiting toxicities (DLTs); other assessments included safety, pharmacokinetic profile, antitumour activity according to response evaluation criteria in solid tumours and EGFR/HER1 mutation analysis where possible. RESULTS Twelve evaluable patients were treated at doses of 20-50 mg/day. One DLT was observed at 50 mg/day in Course 1 (Grade 3 mucositis). The most frequent drug-related adverse events were diarrhoea, dry skin, stomatitis, rash, paronychia and anorexia; most were Grade 1 or 2. Six out of 12 patients had tumour size reductions; durable stable disease was achieved in three patients including one with EGFR/HER1 exon 19 and T790 M mutations. Peak plasma concentrations of afatinib were reached 3-4 h after administration and declined with a half-life of 30-40 h. Afatinib 50 mg/day was well tolerated with an acceptable safety profile during Phase I. CONCLUSION Recommended dose for Phase II was defined as 50 mg/day for Japanese patients; the same as for non-Japanese patients.
Collapse
Affiliation(s)
- H Murakami
- Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo Nagaizumi-cho Sunto-gun, Shizuoka 411-8777, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Shahidi M, Hosseini S, Jafari A. Comparison between ED and SDPS plots as the results of wavelet transform for analyzing electrochemical noise data. Electrochim Acta 2011. [DOI: 10.1016/j.electacta.2011.08.091] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
22
|
Janjigian YY, Groen HJ, Horn L, Smit EF, Fu Y, Wang F, Shahidi M, Denis LJ, Pao W, Miller VA. Activity and tolerability of afatinib (BIBW 2992) and cetuximab in NSCLC patients with acquired resistance to erlotinib or gefitinib. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.7525] [Citation(s) in RCA: 76] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
23
|
Yamamoto N, Katakami N, Atagi S, Hida T, Goto K, Horai T, Inoue A, Ichinose Y, Kobayashi K, Takeda K, Kiura K, Saka H, Tamura T, Okamoto I, Nogami N, Morinaga R, Nishio K, Seki Y, Lorence RM, Shahidi M. A phase II trial of afatinib (BIBW 2992) in patients (pts) with advanced non-small cell lung cancer previously treated with erlotinib (E) or gefitinib (G). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.7524] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
24
|
Eisenstat DD, Nabors LB, Mason WP, Perry JR, Shapiro WR, Kavan P, Phuphanich S, Fu Y, Cong XJ, Shahidi M, Reardon DA. A phase II study of daily afatinib (BIBW 2992) with or without temozolomide (21/28 days) in the treatment of patients with recurrent glioblastoma. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.2010] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
25
|
Asghari F, Shahidi M, Chashnidel Y, Deldar H, Ansari-Pirsaraei Z, Mohammadi-Sangcheshmeh A. 205 GLUCOSE-6-PHOSPHATE DEHYDROGENAZE ACTIVITY IN OVINE OOCYTES IS ASSOCIATED WITH PRE-IMPLANTATION EMBRYONIC DEVELOPMENT IN VITRO. Reprod Fertil Dev 2011. [DOI: 10.1071/rdv23n1ab205] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
A large proportion of ovine oocytes fail to develop into viable embryos following maturation, fertilization, and culture in vitro. Accurate, fast, and noninvasive predictors of ovine oocyte quality are therefore in urgent need for oocyte selection before in vitro maturation (IVM). Recent studies have shown that oocyte competence can be predicted through the presence of the glucose-6-phosphate dehydrogenase (G6PD) enzyme, as indicated by brilliant cresyl blue (BCB), a dye that can be degraded by G6PD. Thus, oocytes that have completed their growth phase show decreased G6PD activity and exhibit cytoplasm with a blue colouration (BCB+), whereas growing oocytes are expected to have a high level of G6PD, which results in colourless cytoplasm (BCB–). The brilliant cresyl blue staining test, as a noninvasive intrinsic criterion, has been successfully used to identify the more competent oocytes in various species. Therefore, this study aimed to investigate whether BCB staining, as an indicator of G6PD activity, can be used to select developmentally competent ovine oocytes before IVM and thereby increase the efficiency of in vitro embryo production. Ovine ovaries were obtained from a local slaughterhouse and transported to the laboratory, where cumulus–oocyte complexes (COC) were recovered by slicing the ovaries. Only oocytes with one or more complete layers of unexpanded cumulus cells and a homogeneous cytoplasm were used. The COC were exposed to 26 mM BCB diluted in modified Dulbecco’s PBS for 90 min at 39°C in humidified air. After BCB exposure, the COC were examined under a stereomicroscope and divided into 2 groups: BCB+ (blue cytoplasm, low G6PD activity) and BCB– (colourless cytoplasm, high G6PD activity). Cumulus–oocyte complexes in the control group were incubated for IVM directly after selection, without exposure to BCB dye. After IVM, oocytes were subjected to IVF followed by embryo culture for 7 days (5% CO2, 39°C, humidified air). Results were analysed by a chi-square test, and P < 0.05 was considered statistically significant. The proportion of oocytes that cleaved by Day 2 after insemination was significantly (P < 0.05) higher for the control and BCB+ groups [67.3% (68/101) and 71.7% (81/113), respectively] than for the BCB– group [50.5% (46/91)]. Significant differences among groups were also observed on Day 7 after fertilization, when the embryos reached the blastocyst stage of development. The BCB+ group yielded a significantly (P < 0.05) higher proportion of blastocysts [34.5% (39/113)] than both the control [20.8% (21/101)] and BCB– [4.3% (4/93)] groups. In addition, the blastocyst rate of development in the control group was significantly (P < 0.05) higher than that for the BCB– group. In conclusion, results of this study show that selection of ovine oocytes based on G6PD activity through the BCB test can be used as an efficient predictor of in vitro embryonic developmental competence. This positive predictive parameter of oocyte quality may also be useful in increasing the efficiency of blastocyst production during in vitro embryo production procedures in the ovine.
Collapse
|
26
|
Shahidi M, Mozdarani H, Mueller WU. Radiosensitivity and repair kinetics of gamma-irradiated leukocytes from sporadic prostate cancer patients and healthy individuals assessed by alkaline comet assay. Iran Biomed J 2010; 14:67-75. [PMID: 21079656 PMCID: PMC3904056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 02/13/2010] [Revised: 04/04/2010] [Accepted: 06/13/2010] [Indexed: 05/30/2023]
Abstract
BACKGROUND Impaired DNA repair mechanism is one of the main causes of tumor genesis. Study of intrinsic radiosensitivity of cancer patients in a non-target tissue (e.g. peripheral blood) might show the extent of DNA repair deficiency of cells in affected individuals and might be used a predictor of cancer predisposition. METHODS Initial radiation-induced DNA damage (ratio of Tail DNA/Head DNA), dose-response curves and kinetics of DNA repair in leukocytes from healthy volunteers and prostate cancer patients were assessed using alkaline comet assay after exposure to 60Co gamma rays. RESULTS Results showed that higher levels of baseline and gamma rays induced DNA damage in leukocytes of prostate cancer cases than in controls. A similar dose response was obtained for both groups. After a repair time of 24 h following in vitro irradiation, samples from the healthy individuals showed no residual DNA damage in their leukocytes, whereas prostate cancer patients revealed more than 20 percent. Although similar initial radiosensitivity was observed for both groups, the repair kinetics of radiation induced DNA damage of leukocytes from prostate cancer cases and healthy subjects were statistically different. CONCLUSION These results support the hypothesis that men affected by prostate cancer may have a constitutional genomic instability.
Collapse
Affiliation(s)
- Maryam Shahidi
- Dept. of Medical Physics
- Dept. of Biochemistry and Biophysics, Mazandaran University of Medical Sciences, Sari, Iran
| | - Hossein Mozdarani
- *Corresponding Author; Tel. (+98-21) 8288 3830; Fax: (+98-21) 8800 6544; E-mail:
| | | |
Collapse
|
27
|
Yang C, Shih J, Su W, Hsia T, Tsai C, Ou SI, Calvo R, Cong XJ, Shahidi M, Miller VA. A phase II study of BIBW 2992 in patients with adenocarcinoma of the lung and activating EGFR mutations (LUX-Lung 2). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7521] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
28
|
Pasadhika S, Fishman GA, Choi D, Shahidi M. Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity. Eye (Lond) 2010; 24:756-62; quiz 763. [PMID: 20395978 DOI: 10.1038/eye.2010.21] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
PURPOSE To evaluate macular thickness profiles using spectral-domain optical coherence tomography (SDOCT) and image segmentation in patients with chronic exposure to hydroxychloroquine. METHODS This study included eight patients with chronic exposure to hydroxychloroquine (group 1) and eight controls (group 2). Group 1 patients had no clinically evident retinal toxicity. All subjects underwent SDOCT imaging of the macula. An image segmentation technique was used to measure thickness of six retinal layers at 200 microm intervals. A mixed-effects model was used for multivariate analysis. RESULTS By measuring total retinal thickness either at the central macular (2800 microm in diameter), the perifoveal region 1200-microm-width ring surrounding the central macula), or the overall macular area (5200 microm in diameter), there were no significant differences in the thickness between groups 1 and 2. On an image segmentation analysis, selective thinning of the inner plexiform+ganglion cell layers (P=0.021) was observed only in the perifoveal area of the patients in group 1 compared with that of group 2 by using the mixed-effects model analysis. CONCLUSION Our study results suggest that chronic exposure to hydroxychloroquine is associated with thinning of the perifoveal inner retinal layers, especially in the ganglion cell and inner plexiform layers, even in the absence of functional or structural clinical changes involving the photoreceptor or retinal pigment epithelial cell layers. This may be a contributing factor as the reason most patients who have early detectable signs of drug toxicity present with paracentral or pericentral scotomas.
Collapse
Affiliation(s)
- S Pasadhika
- Department of Ophthalmology and Visual Sciences, Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL 60612, USA
| | | | | | | |
Collapse
|
29
|
Moattari A, Ashrafi H, Kadivar MR, Kheiri MT, Shahidi M, Arabpour M, Ghanbari A. Antigenic variations of human influenza virus in Shiraz, Iran. Indian J Med Microbiol 2010; 28:114-9. [DOI: 10.4103/0255-0857.62486] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
30
|
Shahidi M, Wanek J, Gaynes B, Wu T. Quantitative assessment of conjunctival microvascular circulation of the human eye. Microvasc Res 2010; 79:109-13. [PMID: 20053367 DOI: 10.1016/j.mvr.2009.12.003] [Citation(s) in RCA: 52] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2009] [Revised: 12/14/2009] [Accepted: 12/19/2009] [Indexed: 11/25/2022]
Abstract
Accessibility to the bulbar conjunctival microvasculature provides a means to assess blood supply to the cerebral cortex and thus optimize therapeutic interventions designed to prevent or reduce the risk of cerebral vascular disease and stroke. The feasibility of a method for quantitative measurements of conjunctiva blood vessel diameter, blood velocity, and flow in the human eye is reported. The method is based on slit lamp biomicroscope digital imaging coupled with a space time image analysis technique. A sequence of conjunctiva microvasculature images was captured at a rate of 50 Hz. The images were analyzed to determine blood vessel diameter, velocity and flow. Blood vessel diameter measurements ranged between 8.7 and 24.3 microns, with a mean value of 15.5 microns. Blood flow rate ranged between 27.3 and 296.9 pl/s, with a mean value of 111.8 pl/s. The relationship between blood flow and vessel diameter was fit with a power law curve (R=0.87). The application of this technique for in vivo quantitative assessment of blood flow dynamics has potential to impact diagnosis and monitoring of various cardiovascular and blood disorders.
Collapse
Affiliation(s)
- M Shahidi
- Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.
| | | | | | | |
Collapse
|
31
|
Ang J, Mikropoulos C, Stavridi F, Rudman S, Uttenreuther-Fisher M, Shahidi M, Pemberton K, Wind S, de Bono J, Spicer JF. A phase I study of daily BIBW 2992, an irreversible EGFR/HER-2 dual kinase inhibitor, in combination with weekly paclitaxel. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e14541] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e14541 Background: BIBW 2992 is an oral, potent and irreversible inhibitor of both EGFR and HER2 receptor tyrosine kinases. The efficacy of cytotoxic agents can be enhanced by erbB inhibition. The primary objective of this Phase I open- label dose-escalation trial was to determine the maximum tolerated dose (MTD) of BIBW 2992 in combination with weekly paclitaxel. Methods: This study evaluated safety, pharmacokinetics (PK), and anti-tumor efficacy of daily BIBW 2992 combined with paclitaxel administered on Days 1, 8 and 15 of a 4-weekly cycle. The dose of paclitaxel was 80 mg/m2, and the BIBW 2992 starting dose was 20 mg, escalated in successive cohorts to 40 then 50 mg. After 6 cycles of combination therapy, patients benefiting and tolerating treatment were eligible to continue single agent BIBW 2992. Results: Sixteen patients with advanced solid tumors expressing erbB receptors and suitable for treatment with a taxane have been enrolled (6 male/10 female; median age: 59 [range: 39–72]; ECOG PS 0/1: 5/11). Two dose-limiting toxicities of fatigue and mucositis occurred at a BIBW 2992 dose of 50 mg. The most frequent adverse events were fatigue, rash, mucositis and diarrhea. Partial responses were seen in patients with non-small cell lung cancer (3), prostate cancer (1), oesophageal cancer (1) and cholangiocarcinoma (1). Eight patients have remained on treatment beyond 4 cycles. The PK data of paclitaxel (with and without BIBW 2992 administration) as well as of BIBW 2992 at steady state (in combination with paclitaxel) will be described. Conclusions: A BIBW 2992 dose of 40 mg daily in combination with weekly paclitaxel 80 mg/m2 is the likely recommended dose for Phase II study. Promising anti-tumor activity was seen with this combination. The addition of bevacizumab to BIBW 2992 with 80 mg/m2 weekly paclitaxel is now being evaluated. Adverse events of BIBW 2992 combined with paclitaxel were generally mild to moderate and manageable. [Table: see text]
Collapse
Affiliation(s)
- J. Ang
- Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; Guy's and St Thomas’ Hospital, London, United Kingdom; Boehringer Ingelheim, Biberach, Germany; Boehringer Ingelheim Ltd UK, Bracknell, United Kingdom
| | - C. Mikropoulos
- Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; Guy's and St Thomas’ Hospital, London, United Kingdom; Boehringer Ingelheim, Biberach, Germany; Boehringer Ingelheim Ltd UK, Bracknell, United Kingdom
| | - F. Stavridi
- Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; Guy's and St Thomas’ Hospital, London, United Kingdom; Boehringer Ingelheim, Biberach, Germany; Boehringer Ingelheim Ltd UK, Bracknell, United Kingdom
| | - S. Rudman
- Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; Guy's and St Thomas’ Hospital, London, United Kingdom; Boehringer Ingelheim, Biberach, Germany; Boehringer Ingelheim Ltd UK, Bracknell, United Kingdom
| | - M. Uttenreuther-Fisher
- Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; Guy's and St Thomas’ Hospital, London, United Kingdom; Boehringer Ingelheim, Biberach, Germany; Boehringer Ingelheim Ltd UK, Bracknell, United Kingdom
| | - M. Shahidi
- Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; Guy's and St Thomas’ Hospital, London, United Kingdom; Boehringer Ingelheim, Biberach, Germany; Boehringer Ingelheim Ltd UK, Bracknell, United Kingdom
| | - K. Pemberton
- Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; Guy's and St Thomas’ Hospital, London, United Kingdom; Boehringer Ingelheim, Biberach, Germany; Boehringer Ingelheim Ltd UK, Bracknell, United Kingdom
| | - S. Wind
- Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; Guy's and St Thomas’ Hospital, London, United Kingdom; Boehringer Ingelheim, Biberach, Germany; Boehringer Ingelheim Ltd UK, Bracknell, United Kingdom
| | - J. de Bono
- Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; Guy's and St Thomas’ Hospital, London, United Kingdom; Boehringer Ingelheim, Biberach, Germany; Boehringer Ingelheim Ltd UK, Bracknell, United Kingdom
| | - J. F. Spicer
- Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; Guy's and St Thomas’ Hospital, London, United Kingdom; Boehringer Ingelheim, Biberach, Germany; Boehringer Ingelheim Ltd UK, Bracknell, United Kingdom
| |
Collapse
|
32
|
Yang C, Hirsh V, Cadranel J, Chen Y, Park K, Kim S, Chao T, Oberdick M, Shahidi M, Miller V. Phase IIb/III double-blind randomized trial of BIBW 2992, an irreversible, dual inhibitor of EGFR and HER2 plus best supportive care (BSC) versus placebo plus BSC in patients with NSCLC failing 1–2 lines of chemotherapy (CT) and erlotinib or gefitinib (LUX- Lung1): A preliminary report. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.8062] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
8062 Background: No approved therapy exists for NSCLC patients (pts) who have failed chemotherapy (CT) and the reversible epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), erlotinib (E) or gefitinib (G). The efficacy of BIBW 2992 (Tovok), a potent, irreversible inhibitor of EGFR and human epidermal growth factor receptor 2 (HER2) with preclinical activity against the secondary resistance mutation T790M, in pts progressing after initial clinical benefit on E/G is being assessed in this randomized trial. Methods: Pts with advanced adenocarcinoma of the lung (Stage IIIB/IV; ECOG 0–2), who have failed one or two lines of CT (including platinum) and progressed following at least 12 weeks of E or G are randomized in a 2:1 ratio to receive BSC plus either oral BIBW 2992 50 mg qd or placebo until disease progression or unacceptable toxicity. Primary endpoint is overall survival, with progression-free survival, objective response and clinical benefit rate and duration, safety and quality of life being secondary endpoints. Enrollment of 400 pts is planned (HR=0.70, 85% power). An unblinded interim analysis of tumor response and safety by the independent Data Monitoring Committee (DMC) after the first 40 evaluable pts treated with BIBW 2992 will determine continuation to full accrual. Results: From May to November 2008, 145 pts have been randomized and 76 are still on treatment. Demographics (n=145): median age 59 (range: 30–82); female 68%, current/ex-smokers 38%; metastatic disease 91%, ECOG 0–1 92%; Asian origin 68%. 50% had one prior line of CT. Main prior EGFR-TKI was G in Asians (70%) and E in non-Asians (85%). 40% of pts had achieved a PR or CR on previous treatment with E/G. Duration of prior E/G treatment was >24 weeks and >48 weeks in 80% and 40% of pts, respectively. As expected, diarrhea, rash, anorexia, stomatitis, paronychia, nausea and vomiting were the most frequently observed adverse events. Conclusions: The trial is continuing recruitment after DMC review of efficacy and safety and updated demographics and blinded safety data will be reported. [Table: see text]
Collapse
Affiliation(s)
- C. Yang
- National Taiwan University Hospital, Taipei, Taiwan; McGill University Health Center, Montreal, QC, Canada; Hôpital Tenon, Paris, France; Veterans General Hospital, Taipei, Taiwan; Samsung Medical Center, Seoul, Republic of Korea; Asan Medical Center, Seoul, Republic of Korea; Tri-Service General Hospital, Taipei, Taiwan; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - V. Hirsh
- National Taiwan University Hospital, Taipei, Taiwan; McGill University Health Center, Montreal, QC, Canada; Hôpital Tenon, Paris, France; Veterans General Hospital, Taipei, Taiwan; Samsung Medical Center, Seoul, Republic of Korea; Asan Medical Center, Seoul, Republic of Korea; Tri-Service General Hospital, Taipei, Taiwan; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - J. Cadranel
- National Taiwan University Hospital, Taipei, Taiwan; McGill University Health Center, Montreal, QC, Canada; Hôpital Tenon, Paris, France; Veterans General Hospital, Taipei, Taiwan; Samsung Medical Center, Seoul, Republic of Korea; Asan Medical Center, Seoul, Republic of Korea; Tri-Service General Hospital, Taipei, Taiwan; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - Y. Chen
- National Taiwan University Hospital, Taipei, Taiwan; McGill University Health Center, Montreal, QC, Canada; Hôpital Tenon, Paris, France; Veterans General Hospital, Taipei, Taiwan; Samsung Medical Center, Seoul, Republic of Korea; Asan Medical Center, Seoul, Republic of Korea; Tri-Service General Hospital, Taipei, Taiwan; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - K. Park
- National Taiwan University Hospital, Taipei, Taiwan; McGill University Health Center, Montreal, QC, Canada; Hôpital Tenon, Paris, France; Veterans General Hospital, Taipei, Taiwan; Samsung Medical Center, Seoul, Republic of Korea; Asan Medical Center, Seoul, Republic of Korea; Tri-Service General Hospital, Taipei, Taiwan; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - S. Kim
- National Taiwan University Hospital, Taipei, Taiwan; McGill University Health Center, Montreal, QC, Canada; Hôpital Tenon, Paris, France; Veterans General Hospital, Taipei, Taiwan; Samsung Medical Center, Seoul, Republic of Korea; Asan Medical Center, Seoul, Republic of Korea; Tri-Service General Hospital, Taipei, Taiwan; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - T. Chao
- National Taiwan University Hospital, Taipei, Taiwan; McGill University Health Center, Montreal, QC, Canada; Hôpital Tenon, Paris, France; Veterans General Hospital, Taipei, Taiwan; Samsung Medical Center, Seoul, Republic of Korea; Asan Medical Center, Seoul, Republic of Korea; Tri-Service General Hospital, Taipei, Taiwan; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - M. Oberdick
- National Taiwan University Hospital, Taipei, Taiwan; McGill University Health Center, Montreal, QC, Canada; Hôpital Tenon, Paris, France; Veterans General Hospital, Taipei, Taiwan; Samsung Medical Center, Seoul, Republic of Korea; Asan Medical Center, Seoul, Republic of Korea; Tri-Service General Hospital, Taipei, Taiwan; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - M. Shahidi
- National Taiwan University Hospital, Taipei, Taiwan; McGill University Health Center, Montreal, QC, Canada; Hôpital Tenon, Paris, France; Veterans General Hospital, Taipei, Taiwan; Samsung Medical Center, Seoul, Republic of Korea; Asan Medical Center, Seoul, Republic of Korea; Tri-Service General Hospital, Taipei, Taiwan; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - V. Miller
- National Taiwan University Hospital, Taipei, Taiwan; McGill University Health Center, Montreal, QC, Canada; Hôpital Tenon, Paris, France; Veterans General Hospital, Taipei, Taiwan; Samsung Medical Center, Seoul, Republic of Korea; Asan Medical Center, Seoul, Republic of Korea; Tri-Service General Hospital, Taipei, Taiwan; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| |
Collapse
|
33
|
Shih J, Yang C, Su W, Hsia T, Tsai C, Chen Y, Chang H, Terlizzi E, Shahidi M, Miller VA. A phase II study of BIBW 2992, a novel irreversible dual EGFR and HER2 tyrosine kinase inhibitor (TKI), in patients with adenocarcinoma of the lung and activating EGFR mutations after failure of one line of chemotherapy (LUX-Lung 2). J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.8013] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
8013 Background: EGFR mutations are associated with exquisite sensitivity to EGFR TKIs in NSCLC. A phase II trial evaluating the efficacy of BIBW 2992 (Tovok), a novel, potent, irreversible, dual EGFR and HER2 TKI with preclinical activity in cell lines harboring activating (H3255, IC50=0.7 nM) and resistant (H1975, IC50=99 nM) EGFR mutations, is reported. Methods: Objective response rate is the primary endpoint of this 2-stage trial. Based on 16 or more unconfirmed PRs in an interim analysis of the first 40 2nd line patients (pts) completing 1 course (28 days), accrual will continue to a total of 120 1st and 2nd line pts (expected completion of accrual by May 2009. Data on 2nd line pts only are presented). Eligible pts have stage IIIB/IV lung adenocarcinoma, EGFR mutation in exons 18–21 (tested by direct sequencing), measurable disease, ECOG PS 0–2 and adequate end organ function. Pts receive 50 mg BIBW 2992 qd until progression. Tumor assessments are performed every 4 weeks for 12 weeks, then every 8 weeks. Results: Since Oct 2007, samples from 289 pts (222 from Taiwan and 67 from the US) have been sequenced. 100 had detectable EGFR mutations including del19 (n=39), L858R (n=45) and others (n=16). 69 pts have started treatment. The trial was moved to stage 2 after 21 of the first 38 treated pts had objective response at 28 days. Of 55 evaluable 2nd line pts, 29 (53%) had PR, and 23 (42%) had SD. Median follow up is 5.1 months. Most common related AEs were diarrhea and skin-related AEs, reported in 87% and 88% of pts, respectively. 27 pts (42.9 %) had dose reduction to 40 mg and 7 pts (11%) to 30 mg but only 1 pt permanently discontinued due to AEs. Diarrhea and rash were main causes of dose reduction. Conclusions: In the 2nd line setting, BIBW 2992 shows efficacy in NSCLC harboring EGFR activating mutations. Diarrhea and skin disorders, the most frequently observed AEs, are manageable with supportive care and dose reduction. Updated response and disease control rates and preliminary progression-free survival data will be presented. An international Phase III trial program investigating BIBW 2992 in NSCLC, LUX-Lung, is now recruiting. [Table: see text]
Collapse
Affiliation(s)
- J. Shih
- National Taiwan University Hospital, Taipei, Taiwan; National Cheng Kung University Hospital, Tainan, Taiwan; China Medical University Hospital, Taichung, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan; Boehringer Ingelheim, Taipei, Taiwan; Boehringer Ingelheim, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - C. Yang
- National Taiwan University Hospital, Taipei, Taiwan; National Cheng Kung University Hospital, Tainan, Taiwan; China Medical University Hospital, Taichung, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan; Boehringer Ingelheim, Taipei, Taiwan; Boehringer Ingelheim, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - W. Su
- National Taiwan University Hospital, Taipei, Taiwan; National Cheng Kung University Hospital, Tainan, Taiwan; China Medical University Hospital, Taichung, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan; Boehringer Ingelheim, Taipei, Taiwan; Boehringer Ingelheim, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - T. Hsia
- National Taiwan University Hospital, Taipei, Taiwan; National Cheng Kung University Hospital, Tainan, Taiwan; China Medical University Hospital, Taichung, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan; Boehringer Ingelheim, Taipei, Taiwan; Boehringer Ingelheim, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - C. Tsai
- National Taiwan University Hospital, Taipei, Taiwan; National Cheng Kung University Hospital, Tainan, Taiwan; China Medical University Hospital, Taichung, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan; Boehringer Ingelheim, Taipei, Taiwan; Boehringer Ingelheim, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - Y. Chen
- National Taiwan University Hospital, Taipei, Taiwan; National Cheng Kung University Hospital, Tainan, Taiwan; China Medical University Hospital, Taichung, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan; Boehringer Ingelheim, Taipei, Taiwan; Boehringer Ingelheim, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - H. Chang
- National Taiwan University Hospital, Taipei, Taiwan; National Cheng Kung University Hospital, Tainan, Taiwan; China Medical University Hospital, Taichung, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan; Boehringer Ingelheim, Taipei, Taiwan; Boehringer Ingelheim, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - E. Terlizzi
- National Taiwan University Hospital, Taipei, Taiwan; National Cheng Kung University Hospital, Tainan, Taiwan; China Medical University Hospital, Taichung, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan; Boehringer Ingelheim, Taipei, Taiwan; Boehringer Ingelheim, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - M. Shahidi
- National Taiwan University Hospital, Taipei, Taiwan; National Cheng Kung University Hospital, Tainan, Taiwan; China Medical University Hospital, Taichung, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan; Boehringer Ingelheim, Taipei, Taiwan; Boehringer Ingelheim, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| | - V. A. Miller
- National Taiwan University Hospital, Taipei, Taiwan; National Cheng Kung University Hospital, Tainan, Taiwan; China Medical University Hospital, Taichung, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan; Boehringer Ingelheim, Taipei, Taiwan; Boehringer Ingelheim, Ridgefield, CT; Boehringer Ingelheim, Bracknell, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York, NY
| |
Collapse
|
34
|
Soltani Z, Hosseini M, Shahidi M, Hedayati M, Kheiri MT. Molecular analysis of human influenza virus in Tehran, Iran. Intervirology 2009; 52:63-7. [PMID: 19401630 DOI: 10.1159/000214634] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2008] [Accepted: 02/10/2009] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND To date there are no reports of molecular and phylogenetic analyses of human influenza virus in Tehran, Iran. OBJECTIVES We isolated and characterized circulating influenza viruses in a sample of patients in Tehran. METHODS Nasal and pharyngeal swabs were collected from 57 individuals who were suspected of having influenza between October 2005 and January 2007. These samples were cultured and subsequently genotyped by RT-PCR and sequencing analyses. RESULTS Twelve of 57 samples (21%) were positive for human influenza virus. Out of the 12 positive samples, 7 were A/H3N2 (58%), 3 were A/H1N1 (25%) and 2 were B subtypes (17%). The phylogenetic analysis of the hemagglutinin gene showed that the H1N1 isolates were close to the A/New Caledonia/20/99 and the H3N2 isolates were close to the A/Panama/2007/99 and A/Moscow/10/99 vaccine strains. CONCLUSION In a sample of clinical patients in Tehran, Iran, the predominant subtype of human influenza virus was determined to be A/H3N2, followed by A/H1N1 and B. In addition, phylogenetic analysis on H1 showed some genetic drifts from vaccine strains, but the phylogeny of H3 demonstrated that these isolates were from the previous vaccine strains.
Collapse
Affiliation(s)
- Z Soltani
- Influenza Unit, Pasteur Institute of Iran, 12 Farvardin Street, Tehran, Iran
| | | | | | | | | |
Collapse
|
35
|
Stopfer P, Narjes H, Gaschler-Markefski B, Gansser D, Shahidi M. Pharmacokinetics (PK) of [ 14C]-BIBW 2992 after administration of a single dose of 15 mg [ 14C]-BIBW 2992 oral solution in healthy male volunteers. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.14607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
36
|
Yang C, Shih J, Chao T, Tsai C, Yu C, Yang P, Streit M, Shahidi M, Miller VA. Use of BIBW 2992, a novel irreversible EGFR/HER2 TKI, to induce regression in patients with adenocarcinoma of the lung and activating EGFR mutations: Preliminary results of a single-arm phase II clinical trial. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.8026] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
37
|
Shahidi M, Mozdarani H, Bryant PE. Radiation sensitivity of leukocytes from healthy individuals and breast cancer patients as measured by the alkaline and neutral comet assay. Cancer Lett 2007; 257:263-73. [PMID: 17881118 DOI: 10.1016/j.canlet.2007.08.002] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2007] [Revised: 06/30/2007] [Accepted: 08/01/2007] [Indexed: 10/22/2022]
Abstract
Initial radiation-induced DNA damage, dose-response curves and kinetics of DNA repair in leukocytes from healthy volunteers and breast cancer patients, was assessed using alkaline and neutral comet assay after exposure to (60)Co gamma rays. Both versions of comet assay showed higher levels of baseline DNA damage in leukocytes of breast cancer cases than in controls. Gamma ray induced initial DNA damage in leukocytes of cancer cases was not significantly different from that of healthy donors. A similar dose-response was obtained with both versions of comets for two groups. After a repair time of 24h, following irradiation, samples from the healthy individuals showed no residual DNA damage in their leukocytes, whereas breast cancer patients revealed more than 20%. Although similar initial radiosensitivity was observed for both groups but the repair kinetics of radiation-induced DNA damage of leukocytes from breast cancer cases and healthy subjects was statistically different.
Collapse
Affiliation(s)
- Maryam Shahidi
- Department of Medical Physics, Tarbiat Modares University, Tehran, Iran
| | | | | |
Collapse
|
38
|
Plummer R, Vidal L, Perrett R, Spicer J, Stopfer P, Shahidi M, Temple G, Futreal A, Calvert H, de Bono J. 703 POSTER A phase I and pharmacokinetic (PK) study of BIBW 2992, an oral irreversible dual EGFR/HER2 inhibitor. EJC Suppl 2007. [DOI: 10.1016/s1359-6349(07)70502-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
39
|
Shakoor A, Gupta M, Blair N, Shahidi M. Chorioretinal vascular oxygen tension in spontaneously breathing anesthetized rats. Ophthalmic Res 2007; 39:103-7. [PMID: 17284937 PMCID: PMC2883832 DOI: 10.1159/000099246] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2006] [Accepted: 10/19/2006] [Indexed: 11/19/2022]
Abstract
PURPOSE To establish baseline and variability of oxygen tension (PO(2)) measurements in the choroid, retinal arteries, capillaries, and veins of spontaneously breathing anesthetized rats and determine the effect of a moderate surgical procedure on the chorioretinal PO(2). METHODS Our previously established optical section phosphorescence imaging technique was utilized to measure PO(2) in the chorioretinal vasculatures. Imaging was performed in 29 spontaneously breathing rats under ketamine/xylazine anesthesia. In 7 rats, blood was drawn using a surgically implanted femoral arterial catheter and analyzed to determine the systemic arterial PO(2). The PO(2) measurements in 22 rats without surgery (group 1) and 7 surgically instrumented rats (group 2) were statistically compared. The intrasubject variability was calculated by the average standard deviation (SD) of repeated measurements. RESULTS The average systemic arterial PO(2) was 52 +/- 7 mm Hg (mean +/- SD) in group 2. In group 1, the average PO(2) measurements in the choroid, retinal arteries, capillaries, and veins were 50 +/- 11, 40 +/- 5, 39 +/- 6, and 30 +/- 5 mm Hg, respectively. No statistically significant PO(2) differences in any of the chorioretinal vasculatures were found between the two groups (p > 0.4). The intrasubject variability was 3 mm Hg in the choroid, retinal arteries, capillaries, and veins. CONCLUSIONS Chorioretinal PO(2) measurements in spontaneously breathing anesthetized rats have a relatively low variability, indicating that PO(2) changes due to various physiological alterations can be reliably assessed.
Collapse
Affiliation(s)
| | | | | | - M. Shahidi
- *Mahnaz Shahidi, PhD, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 1855 West Taylor Street, Chicago IL 60612 (USA), Tel. +1 312 413 7364, Fax +1 312 413 7366, E-Mail
| |
Collapse
|
40
|
Plummer R, Vidal L, Li L, Shaw H, Perrett R, Shahidi M, Amelsberg A, Temple G, Calvert H, de Bono J. 573 POSTER Phase I study of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, showing activity in tumors with mutated EGFR. EJC Suppl 2006. [DOI: 10.1016/s1359-6349(06)70578-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
41
|
Mangar SA, Foo K, Norman A, Khoo V, Shahidi M, Dearnaley DP, Horwich A, Huddart RA. Evaluating the Effect of Reducing the High-dose Volume on the Toxicity of Radiotherapy in the Treatment of Bladder Cancer. Clin Oncol (R Coll Radiol) 2006; 18:466-73. [PMID: 16909970 DOI: 10.1016/j.clon.2006.04.008] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
AIMS The radiation dose used to treat bladder cancer is limited by the risk of inducing severe late bladder toxicity. Retrospective data suggest that radiation tolerance is greater for partial rather than whole bladder irradiation. Limiting the high-dose region to a section of the bladder may reduce toxicity, opening the way for dose escalation. The aims of this study were to establish the efficacy and compare the late toxicity between (1) a two-phase technique limiting the high-dose area and (2) a conventional single-phase radiotherapy to the whole bladder. MATERIALS AND METHODS A cohort study was undertaken of 229 patients with invasive bladder cancer treated with computed tomography-planned radical radiotherapy at the Royal Marsden Hospital from 1984 to 1998. In total, 154 patients received a single-phase treatment to the whole bladder with a 2 cm margin. Seventy-five patients with solitary, well-localised tumours were selected for treatment using a two-phase technique. The first phase (12 Gy) aimed to treat the tumour with a 2 cm margin. A second phase treated the whole bladder with 52 Gy. One hundred and forty-one patients were planned to receive a dose of 60-64 Gy/30-32 fractions over 6-6.5 weeks, whereas 88 patients received an accelerated regime. Data on late bladder and bowel toxicity (using Radiation Therapy Oncology Group criteria) were collected prospectively at the annual review. RESULTS At the 5-year follow-up there was no difference in overall survival (hazard ratio = 0.91, 95% confidence interval 0.64-1.3) or failure-free survival (hazard ratio = 1.02, 95% confidence interval 0.73-1.43) between the two techniques. The two-phase reduced volume treatment was less toxic, with a 19% absolute reduction in overall grade 3-4 late toxicity (P = 0.02). These differences were more marked for bladder toxicity compared with bowel toxicity. CONCLUSIONS The two-phase reduced volume technique was associated with less bladder and bowel toxicity than conventional whole bladder radiotherapy without evidence of impaired survival.
Collapse
Affiliation(s)
- S A Mangar
- Academic Radiotherapy, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK
| | | | | | | | | | | | | | | |
Collapse
|
42
|
Abstract
PURPOSE To report the feasibility of retinal thickness mapping for evaluating thickness differences in retinal areas with and without leakage shown by fluorescein angiography for patients who have age-related macular degeneration with choroidal neovascularization. METHODS A custom-built version of the retinal thickness analyzer was used for thickness mapping. Retinal thickness was defined as the separation between vitreoretinal and pigment epithelium-choroid interfaces. Imaging was performed in 1 eye of 10 patients with the clinical diagnoses of age-related macular degeneration and choroidal neovascularization. Patients either had never undergone photodynamic therapy at the time of measurement (untreated) or had received one or more photodynamic therapy treatments (treated). Average retinal thicknesses in selected areas with and without the presence of leakage shown by fluorescein angiography were calculated and compared statistically. RESULTS Retinal thickness (mean +/- SD) in areas with leakage (315 +/- 54 microm) was significantly greater than that in areas without leakage (280 +/- 28 microm) (P = 0.03). In untreated patients, areas with leakage (345 +/- 45 microm) were significantly thicker than areas without leakage (289 +/- 23 microm) (P = 0.02). In treated patients, retinal thickness in areas with leakage (271 +/- 33 microm) and without leakage (267 +/- 34 microm) was similar. CONCLUSION Retinal thickness mapping may prove to be useful as an adjunct to fluorescein angiography to monitor choroidal neovascularization and its treatment.
Collapse
Affiliation(s)
- A Shakoor
- Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 60612, USA
| | | | | | | | | |
Collapse
|
43
|
Murthy V, Norman A, Shahidi M, Parker C, Huddart R, Bange A, Horwich A, Dearnaley D. Time Course of Recovery of Serum Testosterone Following Short Course Neo Adjuvant LHRH Analogue and Radical Radiotherapy in Localised Prostate Cancer. Int J Radiat Oncol Biol Phys 2005. [DOI: 10.1016/j.ijrobp.2005.07.518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
44
|
Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J, Dearnaley DP. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 2003; 21:1513-23. [PMID: 12697875 DOI: 10.1200/jco.2003.04.173] [Citation(s) in RCA: 372] [Impact Index Per Article: 17.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
PURPOSE To assess the risk of cardiovascular morbidity and cardiac risk factors in long-term survivors of testicular cancer according to treatment received. PATIENTS AND METHODS All resident male patients registered in the United Kingdom between 1982 and 1992 attending for follow-up were eligible for recruitment. Patients completed a current health questionnaire and underwent clinical review, along with hematologic, biochemical, and hormonal profiles. For patients not under routine review, follow-up information was sought from their general practitioner and mortality data were sought from the Office of National Statistics. Descriptive analysis was performed on all variables and comparisons were made among patients treated by orchidectomy and follow-up only, chemotherapy alone (C), radiotherapy alone (RT), and radiotherapy and chemotherapy (C/RT). RESULTS Data on cardiovascular events were available on 992 patients. After a median follow-up of 10.2 years, 68 events had been reported, including 18 deaths. After adjusting for age, increased risk for cardiac events was seen after C (relative risk [RR] = 2.59; 95% confidence interval [CI], 1.15 to 5.84; P =.022), RT (RR = 2.40; 95% CI, 1.04 to 5.45; P =.036), and C/RT (RR = 2.78; 95% CI, 1.09 to 7.07; P =.032). There were no significant differences in cardiac risk factors. On multivariate analysis, age, treatment group, free thyroxine, protein, and magnesium levels were associated with cardiovascular disease. CONCLUSION In long-term survivors of testicular cancer, we observed a two-fold or greater risk of developing cardiovascular disease. This was not due to increases in cardiac risk factors, which suggests a direct or indirect treatment effect. These data support the continued research into the minimization of treatment in good-prognosis testicular cancer.
Collapse
Affiliation(s)
- R A Huddart
- Academic Unit of Radiotherapy and Oncology, Royal Marsden NHS Trust and Institute of Cancer Research, Downs Rd, Sutton, Surrey SM2 5PT, United Kingdom.
| | | | | | | | | | | | | |
Collapse
|
45
|
Dearnaley DP, Norman AR, Shahidi M. In regard to Padula et al., normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. IJROBP 2002;52: 439-443. Int J Radiat Oncol Biol Phys 2002; 54:981; author reply 981. [PMID: 12377353 DOI: 10.1016/s0360-3016(02)03001-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
46
|
Abstract
AIM To determine the relation between alterations in the retinal topography and thickness, visual acuity, and retinal pigment epithelium hypopigmentation in atrophic age related macular degeneration (AMD). METHODS 22 patients, mean age 74 (SD 8) years, with atrophic AMD were recruited. An optical imaging system based on the retinal thickness analyser (RTA) was applied to generate a series of 20 optical section images that encompass 2 mm x 2 mm retinal areas. The optical section images were digitised and analysed to provide topographic maps of the vitreoretinal and chorioretinal surfaces and the retinal thickness. Vitreoretinal and chorioretinal surface elevations and retinal thickness were determined. RESULTS Variation in the vitreoretinal surface height was moderately correlated with visual acuity (r = -0.4; p = 0.03; n = 22). Increase in variation of chorioretinal surface height was correlated with decrease in visual acuity (r = -0.5; p = 0.01; n = 22). The retinal thickness was not associated with visual acuity (r = 0.2; p = 0.2; n=22). Relative height of the vitreoretinal surface in eyes with retinal pigment epithelium (RPE) hypopigmentation was significantly less than eyes without RPE hypopigmentation (p = 0.005). Eyes with and without RPE hypopigmentation had a similar relative height of the chorioretinal surface (p = 0.4). Retinal thickness in eyes with RPE hypopigmentation was less than in eyes without RPE hypopigmentation (p = 0.04). CONCLUSION Mapping of chorioretinal and vitreoretinal topography and retinal thickness provides objective and quantitative measurements of retinal structural abnormalities and shows promise as an adjunct for the evaluation of retinal structural changes due to AMD.
Collapse
|
47
|
Abstract
The Royal Marsden Hospital has adopted a policy for patient selection for the use of adjuvant radiotherapy to prevent heterotopic new bone formation (HTBF) limited to those at greater than 50% risk. The treatment protocol is 7 Gy post-operative megavoltage radiotherapy at mid-plane, in one fraction, given within 72 h of surgery. Since the introduction of this protocol in 1993, 26 joints have been treated in 25 patients. The majority of cases were young people with acetabular fractures resulting from road traffic accidents, often alcohol related. Follow-up studies in this group of patients has proved difficult, as many fail to attend for follow up, and others have moved out of the catchment area. Of the 14 cases for which follow-up data is available, 13 remain fully mobile. One has not mobilized since the time of treatment and continues to use crutches. There is one case of recurrent HTBF seen on X-ray after 8 months, but the joint was mobile. By 5 years, all cases have failed to attend for follow-up. The true long-term risks of this treatment policy may not be known for 30 years. The failure of patients to attend even short-term follow-up is a potential problem for clinical oncologists.
Collapse
Affiliation(s)
- P G S Cornes
- Department of Radiotherapy, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, UK
| | | | | |
Collapse
|
48
|
Shahidi M, Norman AR, Gadd J, Huddart RA, Horwich A, Dearnaley DP. Recovery of serum testosterone, LH and FSH levels following neoadjuvant hormone cytoreduction and radical radiotherapy in localized prostate cancer. Clin Oncol (R Coll Radiol) 2002; 13:291-5. [PMID: 11554629 DOI: 10.1053/clon.2001.9272] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
This study was carried out to evaluate the possible long-term endocrine effect of short-term neoadjuvant leuteinizing hormone-releasing hormone analogue (LHRHa) administration in localized prostate cancer. A total of 419 men were treated for 3-6 months at The Royal Marsden NHS Trust by neoadjuvant androgen suppression using monthly depot injections of LHRHa before radical radiotherapy. Serum testosterone (852 measurements), leuteinizing hormone (LH) (799 measurements), and follicle-stimulating hormone (FSH) levels (801 measurements) were grouped according to their timing in relation to hormonal treatment and then analysed. Suppression of pituitary gonadotrophins and testosterone after the administration of LHRHa and their recovery after cessation of the drug was clearly observed. Median serum testosterone levels decreased from 16 nmol/l to 14 nmol/l when comparing prehormonal and follow-up phases. The same comparison showed an increase in median serum LH and FSH levels, with the median LH rising from 5 u/l to 8 u/l and the median serum FSH rising from 6 u/l to 20 u/l. On long-term follow-up, three of 256 men have remained with testosterone levels in the castrate range. Similar highly significant results were seen in subgroup of 103 men who had both pre-LHRHa and follow-up hormone levels analysed (P=0.012, P<0.001, P<0.001 for testosterone, LH and FSH respectively). Our data suggest the possibility of residual gonadal dysfunction after short-term LHRHa administration and radical radiotherapy in localized prostate cancer. Serum testosterone levels are restored to normal levels in the majority of patients, with a compensatory increase in serum levels of LH.
Collapse
Affiliation(s)
- M Shahidi
- Academic Department of Radiotherapy and Oncology, The Royal Marsden NHS Trust, The Institute of Cancer Research, Sutton, UK.
| | | | | | | | | | | |
Collapse
|
49
|
Shahidi M, Norman AR, Gadd J, Huddart RA, Horwich A, Dearnaley DP. Recovery of serum testosterone, LH and FSH levels following neoadjuvant hormone cytoreduction and radical radiotherapy in localized prostate cancer. Clin Oncol (R Coll Radiol) 2002. [PMID: 11554629 DOI: 10.1007/s001740170058] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
This study was carried out to evaluate the possible long-term endocrine effect of short-term neoadjuvant leuteinizing hormone-releasing hormone analogue (LHRHa) administration in localized prostate cancer. A total of 419 men were treated for 3-6 months at The Royal Marsden NHS Trust by neoadjuvant androgen suppression using monthly depot injections of LHRHa before radical radiotherapy. Serum testosterone (852 measurements), leuteinizing hormone (LH) (799 measurements), and follicle-stimulating hormone (FSH) levels (801 measurements) were grouped according to their timing in relation to hormonal treatment and then analysed. Suppression of pituitary gonadotrophins and testosterone after the administration of LHRHa and their recovery after cessation of the drug was clearly observed. Median serum testosterone levels decreased from 16 nmol/l to 14 nmol/l when comparing prehormonal and follow-up phases. The same comparison showed an increase in median serum LH and FSH levels, with the median LH rising from 5 u/l to 8 u/l and the median serum FSH rising from 6 u/l to 20 u/l. On long-term follow-up, three of 256 men have remained with testosterone levels in the castrate range. Similar highly significant results were seen in subgroup of 103 men who had both pre-LHRHa and follow-up hormone levels analysed (P=0.012, P<0.001, P<0.001 for testosterone, LH and FSH respectively). Our data suggest the possibility of residual gonadal dysfunction after short-term LHRHa administration and radical radiotherapy in localized prostate cancer. Serum testosterone levels are restored to normal levels in the majority of patients, with a compensatory increase in serum levels of LH.
Collapse
Affiliation(s)
- M Shahidi
- Academic Department of Radiotherapy and Oncology, The Royal Marsden NHS Trust, The Institute of Cancer Research, Sutton, UK.
| | | | | | | | | | | |
Collapse
|
50
|
Abstract
PURPOSE To report alterations in the retinal topography and thickness in typical cases of age-related macular degeneration (ARMD). METHODS An optical imaging system was applied to patients with ARMD with alterations in the retinal structures. The system generates a series of 20 optical section images that encompass a 2 mm x 2 mm retinal area. The optical sections are digitized and analyzed to provide topographic maps of the vitreo-retinal and chorio-retinal surfaces and the retinal thickness. RESULTS Retinal topography and thickness mapping in a normal eye corresponded to normal anatomy. Topographic mapping in a patient with confluent drusen indicated elevation of the vitreo-retinal surface. Retinal topography in a patient with retinal pigment epithelium detachment displayed localized elevation of the chorio-retinal surface. The thickness map in a patient with geographic atrophy of the retinal pigment epithelium revealed retinal thinning. In the patients with choroidal neovascularization, the vitreoretinal and chorio-retinal surfaces were elevated. The chorio-retinal surface map in a patient with evolving disciform scar displayed topographic variations corresponding to the fibrovascular tissue underlying the serous detachment. CONCLUSION Retinal topography and thickness mapping is useful for visualization and evaluation of pathologic alterations in retinal structures due to ARMD.
Collapse
Affiliation(s)
- J P Gieser
- Department of Ophthalmology and Visual Sciences, UIC Eye Center, University of Illinois at Chicago, 60612, USA
| | | | | | | |
Collapse
|